In addition, although the selective STAT3 inhibitor, S3I‐201, was effective in reducing STAT3 phosphorylation and anti‐myocardial hypertrophy at the cellular level, it displayed a weak ability to inhibit myocardial hypertrophy in animal experiments. The gene discussed is STAT3; the disease is cardiac hypertrophy.